Skip to main content
Top
Gepubliceerd in: Journal of Autism and Developmental Disorders 3/2010

01-03-2010 | Original Paper

Psychotropic Medication Use Among Children With Autism Spectrum Disorders Enrolled in a National Registry, 2007–2008

Auteurs: Rebecca E. Rosenberg, David S. Mandell, Janet E. Farmer, J. Kiely Law, Alison R. Marvin, Paul A. Law

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 3/2010

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Patterns of current psychotropic medication use among 5,181 children with autism spectrum disorders (ASD) enrolled in a Web-based registry were examined. Overall, 35% used at least one psychotropic medication, most commonly stimulants, neuroleptics, and/or antidepressants. Those who were uninsured or exclusively privately insured were less likely to use ≥3 medications than were those insured by Medicaid. Psychiatrists and neurologists prescribed the majority of psychotropic medications. In multivariate analysis, older age, presence of intellectual disability or psychiatric comorbidity, and residing in a poorer county or in the South or Midwest regions of the United States increased the odds of psychotropic medication use. Factors external to clinical presentation likely affect odds of psychotropic medication use among children with ASD.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
go back to reference Aman, M. G., Lam, K. S., & Van Bourgondien, M. E. (2005). Medication patterns in patients with autism: Temporal, regional, and demographic influences. Journal of Child and Adolescent Psychopharmacology, 15(1), 116–126.CrossRefPubMed Aman, M. G., Lam, K. S., & Van Bourgondien, M. E. (2005). Medication patterns in patients with autism: Temporal, regional, and demographic influences. Journal of Child and Adolescent Psychopharmacology, 15(1), 116–126.CrossRefPubMed
go back to reference Aman, M. G., & Langworthy, K. S. (2000). Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders. Journal of Autism and Developmental Disorders, 30(5), 451–459.CrossRefPubMed Aman, M. G., & Langworthy, K. S. (2000). Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders. Journal of Autism and Developmental Disorders, 30(5), 451–459.CrossRefPubMed
go back to reference American Society of Health System Pharmacists. (2006). AHFS drug information. Bethesda, MD: American Society of Health-System Pharmacists. American Society of Health System Pharmacists. (2006). AHFS drug information. Bethesda, MD: American Society of Health-System Pharmacists.
go back to reference American Psychiatric Association. (2000). Disorders usually first diagnosed in infancy, childhood, or Adolescence. Diagnostic and statistical manual of mental disorders, fourth edition, text revision (DSM-IV-TR) (Fourth, Text Revision ed.). Arlington, VA: American Psychiatric Association. doi:10.1176/appi.books.9780890423349. American Psychiatric Association. (2000). Disorders usually first diagnosed in infancy, childhood, or Adolescence. Diagnostic and statistical manual of mental disorders, fourth edition, text revision (DSM-IV-TR) (Fourth, Text Revision ed.). Arlington, VA: American Psychiatric Association. doi:10.​1176/​appi.​books.​9780890423349.
go back to reference Bebbington, A., Anderson, A., Ravine, D., Fyfe, S., Pineda, M., de Klerk, N., et al. (2008). Investigating genotype–phenotype relationships in rett syndrome using an international data set. Neurology, 70(11), 868–875.CrossRefPubMed Bebbington, A., Anderson, A., Ravine, D., Fyfe, S., Pineda, M., de Klerk, N., et al. (2008). Investigating genotype–phenotype relationships in rett syndrome using an international data set. Neurology, 70(11), 868–875.CrossRefPubMed
go back to reference Berument, S. K., Rutter, M., Lord, C., Pickles, A., & Bailey, A. (1999). Autism screening questionnaire: Diagnostic validity. The British Journal of Psychiatry: The Journal of Mental Science, 175, 444–451.CrossRef Berument, S. K., Rutter, M., Lord, C., Pickles, A., & Bailey, A. (1999). Autism screening questionnaire: Diagnostic validity. The British Journal of Psychiatry: The Journal of Mental Science, 175, 444–451.CrossRef
go back to reference Best, S. J., & Krueger, B. S. (2004). Internet data collection. Thousand Oaks, CA: Sage. Best, S. J., & Krueger, B. S. (2004). Internet data collection. Thousand Oaks, CA: Sage.
go back to reference Bryson, S. E., Rogers, S. J., & Fombonne, E. (2003). Autism spectrum disorders: Early detection, intervention, education, and psychopharmacological management. Canadian Journal of Psychiatry (Revue Canadienne De Psychiatrie), 48(8), 506–516. Bryson, S. E., Rogers, S. J., & Fombonne, E. (2003). Autism spectrum disorders: Early detection, intervention, education, and psychopharmacological management. Canadian Journal of Psychiatry (Revue Canadienne De Psychiatrie), 48(8), 506–516.
go back to reference Chen, A. Y., & Chang, R. K. (2002). Factors associated with prescription drug expenditures among children: An analysis of the medical expenditure panel survey. Pediatrics, 109(5), 728–732.CrossRefPubMed Chen, A. Y., & Chang, R. K. (2002). Factors associated with prescription drug expenditures among children: An analysis of the medical expenditure panel survey. Pediatrics, 109(5), 728–732.CrossRefPubMed
go back to reference de Bildt, A., Mulder, E. J., Scheers, T., Minderaa, R. B., & Tobi, H. (2006). Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation. Pediatrics, 118(6), e1860–e1866.CrossRefPubMed de Bildt, A., Mulder, E. J., Scheers, T., Minderaa, R. B., & Tobi, H. (2006). Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation. Pediatrics, 118(6), e1860–e1866.CrossRefPubMed
go back to reference Farmer, J. E., Marvine, A., Law, K., & Anderson, C. (2009). The impact of urbanicity on diagnosis and treatment of ASD. Presented at IMFAR, Chicago, IL. Farmer, J. E., Marvine, A., Law, K., & Anderson, C. (2009). The impact of urbanicity on diagnosis and treatment of ASD. Presented at IMFAR, Chicago, IL.
go back to reference Filipek, P. A., Accardo, P. J., Ashwal, S., Baranek, G. T., Cook, E. H., Jr, Dawson, G., et al. (2000). Practice parameter: Screening and diagnosis of autism: Report of the quality standards subcommittee of the American academy of neurology and the child neurology society. Neurology, 55(4), 468–479.PubMed Filipek, P. A., Accardo, P. J., Ashwal, S., Baranek, G. T., Cook, E. H., Jr, Dawson, G., et al. (2000). Practice parameter: Screening and diagnosis of autism: Report of the quality standards subcommittee of the American academy of neurology and the child neurology society. Neurology, 55(4), 468–479.PubMed
go back to reference Findling, R. L. (2005). Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders. The Journal of Clinical Psychiatry, 66(Suppl 10), 26–31.PubMed Findling, R. L. (2005). Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders. The Journal of Clinical Psychiatry, 66(Suppl 10), 26–31.PubMed
go back to reference Gosling, S. D., Vazire, S., Srivastava, S., & John, O. P. (2004). Should we trust web-based studies? A comparative analysis of six preconceptions about internet questionnaires. American Psychologist, 59(2), 93–104.CrossRefPubMed Gosling, S. D., Vazire, S., Srivastava, S., & John, O. P. (2004). Should we trust web-based studies? A comparative analysis of six preconceptions about internet questionnaires. American Psychologist, 59(2), 93–104.CrossRefPubMed
go back to reference Green, V. A., Pituch, K. A., Itchon, J., Choi, A., O’Reilly, M., & Sigafoos, J. (2006). Internet survey of treatments used by parents of children with autism. Research in Developmental Disabilities, 27(1), 70–84.CrossRefPubMed Green, V. A., Pituch, K. A., Itchon, J., Choi, A., O’Reilly, M., & Sigafoos, J. (2006). Internet survey of treatments used by parents of children with autism. Research in Developmental Disabilities, 27(1), 70–84.CrossRefPubMed
go back to reference Hewson, C., Yule, P., Laurent, D., & Vogel, C. (2003). Internet research methods: A practical guide for the social and behavioral sciences. London: Sage. Hewson, C., Yule, P., Laurent, D., & Vogel, C. (2003). Internet research methods: A practical guide for the social and behavioral sciences. London: Sage.
go back to reference Hoagwood, K., Jensen, P. S., Feil, M., Vitiello, B., & Bhatara, V. S. (2000). Medication management of stimulants in pediatric practice settings: A national perspective. Journal of Developmental and Behavioral Pediatrics: JDBP, 21(5), 322–331.PubMed Hoagwood, K., Jensen, P. S., Feil, M., Vitiello, B., & Bhatara, V. S. (2000). Medication management of stimulants in pediatric practice settings: A national perspective. Journal of Developmental and Behavioral Pediatrics: JDBP, 21(5), 322–331.PubMed
go back to reference Langworthy-Lam, K. S., Aman, M. G., & Van Bourgondien, M. E. (2002). Prevalence and patterns of use of psychoactive medicines in individuals with autism in the autism society of North Carolina. Journal of Child and Adolescent Psychopharmacology, 12(4), 311–321.CrossRefPubMed Langworthy-Lam, K. S., Aman, M. G., & Van Bourgondien, M. E. (2002). Prevalence and patterns of use of psychoactive medicines in individuals with autism in the autism society of North Carolina. Journal of Child and Adolescent Psychopharmacology, 12(4), 311–321.CrossRefPubMed
go back to reference Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E. (2008). Psychotropic medication use among medicaid-enrolled children with autism spectrum disorders. Pediatrics, 121(3), e441–e448.CrossRefPubMed Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E. (2008). Psychotropic medication use among medicaid-enrolled children with autism spectrum disorders. Pediatrics, 121(3), e441–e448.CrossRefPubMed
go back to reference Mandell, D. S., & Palmer, R. (2005). Differences among states in the identification of autistic spectrum disorders. Archives of Pediatrics and Adolescent Medicine, 159(3), 266–269.CrossRefPubMed Mandell, D. S., & Palmer, R. (2005). Differences among states in the identification of autistic spectrum disorders. Archives of Pediatrics and Adolescent Medicine, 159(3), 266–269.CrossRefPubMed
go back to reference Martin, A., Scahill, L., Klin, A., & Volkmar, F. R. (1999). Higher-functioning pervasive developmental disorders: Rates and patterns of psychotropic drug use. Journal of the American Academy of Child and Adolescent Psychiatry, 38(7), 923–931.CrossRefPubMed Martin, A., Scahill, L., Klin, A., & Volkmar, F. R. (1999). Higher-functioning pervasive developmental disorders: Rates and patterns of psychotropic drug use. Journal of the American Academy of Child and Adolescent Psychiatry, 38(7), 923–931.CrossRefPubMed
go back to reference Martin, A., Sherwin, T., Stubbe, D., Van Hoof, T., Scahill, L., & Leslie, D. (2002). Datapoints: Use of multiple psychotropic drugs by medicaid-insured and privately insured children. Psychiatric Services (Washington, D.C.), 53(12), 1508. Martin, A., Sherwin, T., Stubbe, D., Van Hoof, T., Scahill, L., & Leslie, D. (2002). Datapoints: Use of multiple psychotropic drugs by medicaid-insured and privately insured children. Psychiatric Services (Washington, D.C.), 53(12), 1508.
go back to reference Myers, S. M., Johnson, C. P., & American Academy of Pediatrics Council on Children With Disabilities. (2007). Management of children with autism spectrum disorders. Pediatrics, 120(5), 1162–1182.CrossRefPubMed Myers, S. M., Johnson, C. P., & American Academy of Pediatrics Council on Children With Disabilities. (2007). Management of children with autism spectrum disorders. Pediatrics, 120(5), 1162–1182.CrossRefPubMed
go back to reference Olfson, M., Blanco, C., Liu, L., Moreno, C., & Laje, G. (2006). National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry, 63(6), 679–685.CrossRefPubMed Olfson, M., Blanco, C., Liu, L., Moreno, C., & Laje, G. (2006). National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry, 63(6), 679–685.CrossRefPubMed
go back to reference Oswald, D. P., & Sonenklar, N. A. (2007). Medication use among children with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 17(3), 348–355.CrossRefPubMed Oswald, D. P., & Sonenklar, N. A. (2007). Medication use among children with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 17(3), 348–355.CrossRefPubMed
go back to reference Posey, D. J., Stigler, K. A., Erickson, C. A., & McDougle, C. J. (2008). Antipsychotics in the treatment of autism. The Journal of Clinical Investigation, 118(1), 6–14.CrossRefPubMed Posey, D. J., Stigler, K. A., Erickson, C. A., & McDougle, C. J. (2008). Antipsychotics in the treatment of autism. The Journal of Clinical Investigation, 118(1), 6–14.CrossRefPubMed
go back to reference Safer, D. J., Zito, J. M., & Gardner, J. F. (2004). Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youths. Psychiatric Services (Washington, D.C.), 55(9), 1049–1051. Safer, D. J., Zito, J. M., & Gardner, J. F. (2004). Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youths. Psychiatric Services (Washington, D.C.), 55(9), 1049–1051.
go back to reference Shimabukuro, T. T., Grosse, S. D., & Rice, C. (2008). Medical expenditures for children with an autism spectrum disorder in a privately insured population. Journal of Autism and Developmental Disorders, 38(3), 546–552.CrossRefPubMed Shimabukuro, T. T., Grosse, S. D., & Rice, C. (2008). Medical expenditures for children with an autism spectrum disorder in a privately insured population. Journal of Autism and Developmental Disorders, 38(3), 546–552.CrossRefPubMed
go back to reference Tsai, L. Y. (1999). Psychopharmacology in autism. Psychosomatic Medicine, 61(5), 651–665.PubMed Tsai, L. Y. (1999). Psychopharmacology in autism. Psychosomatic Medicine, 61(5), 651–665.PubMed
go back to reference Volkmar, F. R. (2001). Pharmacological interventions in autism: Theoretical and practical issues. Journal of Clinical Child Psychology, 30(1), 80–87.CrossRefPubMed Volkmar, F. R. (2001). Pharmacological interventions in autism: Theoretical and practical issues. Journal of Clinical Child Psychology, 30(1), 80–87.CrossRefPubMed
go back to reference Williams, J., Klinepeter, K., Palmes, G., Pulley, A., & Foy, J. M. (2004). Diagnosis and treatment of behavioral health disorders in pediatric practice. Pediatrics, 114(3), 601–606.CrossRefPubMed Williams, J., Klinepeter, K., Palmes, G., Pulley, A., & Foy, J. M. (2004). Diagnosis and treatment of behavioral health disorders in pediatric practice. Pediatrics, 114(3), 601–606.CrossRefPubMed
go back to reference Witwer, A., & Lecavalier, L. (2005). Treatment incidence and patterns in children and adolescents with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 15(4), 671–681.CrossRefPubMed Witwer, A., & Lecavalier, L. (2005). Treatment incidence and patterns in children and adolescents with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology, 15(4), 671–681.CrossRefPubMed
go back to reference Zito, J. M., Safer, D. J., Zuckerman, I. H., Gardner, J. F., & Soeken, K. (2005). Effect of medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatric Services (Washington, D.C.), 56(2), 157–163. Zito, J. M., Safer, D. J., Zuckerman, I. H., Gardner, J. F., & Soeken, K. (2005). Effect of medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatric Services (Washington, D.C.), 56(2), 157–163.
Metagegevens
Titel
Psychotropic Medication Use Among Children With Autism Spectrum Disorders Enrolled in a National Registry, 2007–2008
Auteurs
Rebecca E. Rosenberg
David S. Mandell
Janet E. Farmer
J. Kiely Law
Alison R. Marvin
Paul A. Law
Publicatiedatum
01-03-2010
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 3/2010
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-009-0878-1

Andere artikelen Uitgave 3/2010

Journal of Autism and Developmental Disorders 3/2010 Naar de uitgave